Bhupesh Singla Has Been Elected As a Fellow of the American Heart Association – UTHSC College of Pharmacy
UTHSC (The University of Tennessee Health Science Center) College of Pharmacy shared a post on LinkedIn:
“Congratulations to Dr. Bhupesh Singla, Assistant Professor in the College of Pharmacy’s Department of Pharmaceutical Sciences, who has been elected as a Fellow of the American Heart Association (FAHA) by the Council on Arteriosclerosis, Thrombosis, and Vascular Biology.
This prestigious honorary title is awarded to physicians, scientists, nurses, and healthcare professionals who have demonstrated a sustained record of excellence and made significant contributions to cardiovascular and stroke research, clinical practice, education, and leadership.
Dr. Singla’s research investigates the role of matricellular proteins in the development and progression of cardiometabolic diseases, including atherosclerosis and metabolic dysfunction-associated steatotic liver disease.
Election as an FAHA recognizes Dr. Singla’s scientific distinction and expertise in cardiovascular research.
His research work has been published in high-impact journals, and he has a strong and consistent record of securing funding for basic science research, including a predoctoral fellowship, two postdoctoral fellowships, an NIH K99/R00 award, an NIH R01 grant, and several institutional intramural grants.
In addition to his research achievements, Dr. Singla is committed to mentoring trainees and actively contributes to service at the institutional, national, and international levels.
‘I am deeply honored to be elected as a Fellow of the American Heart Association,’ said Dr. Singla. ‘This recognition reflects the collective efforts and dedication of my trainees, collaborators, and mentors.’
The AHA is a leading voluntary health organization devoted to fighting cardiovascular disease and stroke.
Fellowship in the AHA recognizes not only scientific accomplishments but also dedication to the organization’s mission to build healthier lives free of cardiovascular disease and stroke.”
Stay updated with Hemostasis Today.
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia
-
Aug 23, 2026, 16:03Balaji Balagani: Major Causes of Sudden Cardiac Death in Children
-
Aug 23, 2026, 16:02Bartosz Hudzik: What’s Hot at ESC Congress 2026